Alisha Banafar*

STABILITY-INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE IN A COMBINED SYNTHETIC MIXTURE

Background: Fixed-dose combination tablets containing an angiotensin II receptor blocker and a calcium channel blocker have achieved widespread acceptance for the management of essential hypertension. Despite extensive clinical utilization, a single stability-indicating assay cap...

STABILITY-INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE IN A COMBINED SYNTHETIC MIXTURE

Background: Fixed-dose combination tablets containing an angiotensin II receptor blocker and a calcium channel blocker have achieved widespread acceptance for the management of essential hypertension. Despite extensive clinical utilization, a single stability-indicating assay cap...

FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ONDANSETRON USING SUPERDISINTEGRANTS BLENDS AND INCLUSION COMPLEXATION FOR RAPID ANTIEMETIC THERAPY

Objective: The present work aimed to design and optimize a fast dissolving tablet (FDT) of ondansetron hydrochloride (4 mg) to achieve rapid disintegration, acceptable taste masking, and prompt antiemetic action, thereby enhancing patient compliance in paediatric, geriatric, and...

STABILITY-INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF THE ANTIDIABETIC AGENTS IN A COMBINED SYNTHETIC MIXTURE

Background: Fixed-dose combination therapy containing a biguanide, a sulfonylurea, and a thiazolidinedione has emerged as a highly effective strategy for managing type 2 diabetes mellitus, particularly in patients with inadequate glycaemic control on dual therapy. Despite widespr...

STABILITY-INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF THE ANTIDIABETIC AGENTS IN A COMBINED SYNTHETIC MIXTURE

Background: Fixed-dose combination therapy containing a biguanide, a sulfonylurea, and a thiazolidinedione has emerged as a highly effective strategy for managing type 2 diabetes mellitus, particularly in patients with inadequate glycaemic control on dual therapy. Despite widespr...

FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ONDANSETRON USING SUPERDISINTEGRANTS BLENDS AND INCLUSION COMPLEXATION FOR RAPID ANTIEMETIC THERAPY

Objective: The present work aimed to design and optimize a fast dissolving tablet (FDT) of ondansetron hydrochloride (4 mg) to achieve rapid disintegration, acceptable taste masking, and prompt antiemetic action, thereby enhancing patient compliance in paediatric, geriatric, and...